Drug Metabolizing Enzyme Market to Register a Steady Revenue CAGR of 7.4% by 2031 | Growth Plus Reports

Newark, New Castle, USA, May 08, 2023 (GLOBE NEWSWIRE) — Growth Plus Reports estimated the size of the global market for drug metabolizing enzymes in 2022 and is expected to increase at a revenue CAGR of 7.4% during the forecast period 2023-2031.

Analysis of the global market for drug metabolizing enzymes indicates that during the forecast period, revenue share is likely to increase significantly. Drugs that are digested by body enzymes are the focus of the drug development and commercialization market, a subset of the pharmaceutical industry. 

Key Takeaways: 

• The rising preference for personalized treatment is driving the market revenue share.
• The advanced technologies for drug metabolizing enzyme research drive market demand.
• The rising R&D studies in CRISPR/Cas9 and gene editing is increasing the market revenue growth rapidly.

Get a Free Sample Research Report: https://growthplusreports.com/inquiry/request-sample/drug-metabolizing-enzyme-market/8916

Drug Metabolizing Enzyme Market Scope

Recent Development in the Drug Metabolizing Enzyme Market: 

• In August 2022, Cypex, a well-known producer of recombinant xenobiotic metabolizing enzymes situated in Dundee, Scotland, was bought by BioIVT LLC. The wide spectrum of proteins involved in drug metabolism is covered by Cypex’s comprehensive enzyme portfolio.

Competitive Landscape

A list of the prominent players operating in the global market for drug metabolizing enzymes includes: 

• Pfizer Inc.
• Thermo Fisher Scientific Inc. 
• Xenotech Technical Services LLC
• Gentest Corporation
• Sekisui XenoTech LLC

Market Drivers and Restraints: 

The global drug metabolizing enzyme market revenue is driven by the rising prevalence of chronic disease and the high demand for tailored medicines. Furthermore, the technological advancements due to several R&D activities related to CRISPR/Cas9 and gene editing are raising the overall market revenue share.

However, due to the strong competition from alternative methods of drug metabolism studies, such as in vitro testing and computer simulations, and stringent regulatory bodies, the drug metabolizing enzyme market revenue growth is expected to be restrained. 

Market Segmentation: 

• Based on Type, Drug Metabolizing Enzyme Market is segmented into Cytochrome P450 (CYP), Sulfotransferase (SULT), UDP-glucuronosyltransferase (UGT), Glutathione S-transferase (GST), and Others. 
• Based on application, the drug metabolizing enzyme market is segmented into personalized medicine, drug discovery & development, diagnostic testing, and research applications.

Segmentation By Type

Based on types, the cytochrome P450 enzyme segment dominates the global drug metabolizing enzyme market with the largest revenue share. This large revenue share is because these metabolize a variety of medicines, poisons from the environment, and other substances in the body.

Regional Growth Dynamics

Based on the region, North America, with the largest revenue share, dominates the global drug metabolizing enzyme market. This large revenue share is because the chronic illness prevalence is high, the desire for individualized medication is rising, and the pharmaceutical business is well-established. Some of the main drivers of the market include factors like the expanding emphasis on drug discovery and development, the rising tendency of outsourcing drug development services to contract research organizations (CROs), and the accessibility of government financing for research and development.

Request for Customization –  https://www.growthplusreports.com/inquiry/customization/drug-metabolizing-enzyme-market/8916

Report Coverage 

Growth Plus Reports conducted extensive research on the world market for drug metabolizing enzymes. We looked at the basic market traits, important investment spheres, regional growth analytics, revenue projections, rival market participants, and mergers and acquisitions.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL DRUG METABOLIZING ENZYME MARKET – ANALYSIS & FORECAST, BY TYPE
   1. Cytochrome P450 (CYP)
   2. Sulfotransferase (SULT)
   3. UDP-glucuronosyltransferase (UGT)
   4. Glutathione S-transferase (GST)
   5. Others
6. GLOBAL DRUG METABOLIZING ENZYME MARKET – ANALYSIS & FORECAST, BY APPLICATION
   1. Personalized Medicine
   2. Drug Discovery & Development 
   3. Diagnostic Testing
   4. Research Applications

DRUG METABOLIZING ENZYME MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8916

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Next-Generation Biomanufacturing Market by Workflow Type (Upstream Biomanufacturing Workflow, Single-Use Upstream Biomanufacturing Workflow), Application (Monoclonal Antibodies, Vaccines), End User (Biopharmaceutical Companies, Research Institutions) – Global Outlook & Forecast 2023-2031

Salivary Gland Infection Therapeutics Market by Site of Infection (Parotid Glands, Submandibular Glands), Drug Class (Antibiotic, NSAIDs) – Global Outlook & Forecast 2023-2031

Severe Asthma Treatment Market by Treatment Type (Long-acting Beta-agonists, Macrolide Antibiotics, Biologic Drugs) – Global Outlook & Forecast 2023-2031

Cellbag Bioreactor Chambers Market by Application Type (Antibody Production, Virus Production), End User Pharmaceutical Companies, Biopharmaceutical Companies) – Global Outlook & Forecast 2023-2031

Mammalian Transient Protein Expression Market by Product Type (Reagents & Consumables, Instruments), Application (Functional Cell-Based Assays, Bio-Production), and End User (Biopharmaceutical Companies, Contract Research Organization) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.